东材科技：2025年净利润同比预增65.73% 1月30日，东材科技(601208)发布业绩预告，2025年度预计实现归属于上市公司股东的净利润为3亿元左 右，同比增加65.73%左右。 航天电子：2025年净利润同比预减55%–65% 1月30日，航天电子(600879)发布业绩预告，预计2025年度实现归属于上市公司股东的净利润为1.92亿元 到2.47亿元，同比减少55%到65%。 欧莱新材：2025年预亏3300万–4800万元 1月30日，欧莱新材(688530)发布业绩预告，预计2025年归母净利亏损3300万-4800万元，上年同期盈利 2816.93万元，同比由盈转亏。 龙建股份：2025年累计中标金额同比增长2.8% 1月30日，龙建股份(600853)发布公告称，公司2025年全年累计中标项目合计金额217.23亿元，同比增长 2.8%。 九鼎新材：2025年净利润同比预增187.68%–231.68% 1月30日，九鼎新材(002201)发布业绩预告，预计2025年归母净利8500万-9800万元，同比增长 187.68%-231.68%。 传艺科技：2025年预盈7800万–1.03亿 ...

证券代码：603168 证券简称：莎普爱思 公告编号：临2026-004 浙江莎普爱思药业股份有限公司 2025年度业绩预亏公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 2.预计2025年度实现归属于母公司所有者的扣除非经常性损益的净利润-34,200.00万元到-22,800.00万 元。 重要内容提示： ● 业绩预告的具体适用情形：净利润为负值 ● 经浙江莎普爱思药业股份有限公司（以下简称"公司"）财务部门初步测算，公司预计2025年度实现归 属于母公司所有者的净利润-31,920.00万元到-21,280.00万元。 ● 公司预计2025年度实现归属于母公司所有者的扣除非经常性损益的净利润-34,200.00万元到-22,800.00 万元。 一、本期业绩预告情况 （一）业绩预告期间 2025年1月1日至2025年12月31日。 （二）业绩预告情况 1.经财务部门初步测算，预计2025年度实现归属于母公司所有者的净利润-31,920.00万元到-21,280.00万 元。 3.本期业绩预告未经注册会计师审计。 二 ...

莎普爱思表示，受外部宏观经济、行业竞争格局加剧等影响下，公司结合内外部环境与下属两家医院实 际及预期经营情况、医疗行业政策变化等综合因素考虑，基于谨慎性原则，对两家医院形成的商誉计提 了商誉减值准备，对本报告期业绩造成较大影响，是导致本期业绩预亏的主要原因。 北京商报讯（记者 丁宁）1月29日晚间，莎普爱思（603168）发布2025年度业绩预亏公告显示，经财务 部门初步测算，公司预计2025年实现归属净利润-2.13亿元到-3.19亿元。 ...

南财智讯1月29日电，莎普爱思发布业绩预亏公告，公司预计2025年度实现归属于母公司所有者的净利 润-31920.00万元到-21280.00万元。2025年度，公司业绩预亏的主要原因：主营业务影响：公司为积极 应对市场环境变化，加大市场开拓力度，积极优化营销策略，主营业务保持稳健的发展。大额减值计 提：受外部宏观经济、行业竞争格局加剧等影响下，公司结合内外部环境与下属两家医院实际及预期经 营情况、医疗行业政策变化等综合因素考虑，基于谨慎性原则，对两家医院形成的商誉计提了商誉减值 准备，对本报告期业绩造成较大影响，是导致本期业绩预亏的主要原因。 ...

莎普爱思公告，预计2025年度归属于母公司所有者的净亏损2.13亿元到3.19亿元。受外部宏观经济、行 业竞争格局加剧等影响下，公司结合内外部环境与下属两家医院实际及预期经营情况、医疗行业政策变 化等综合因素考虑，基于谨慎性原则，对两家医院形成的商誉计提了商誉减值准备，对本报告期业绩造 成较大影响，是导致本期业绩预亏的主要原因。 ...

莎普爱思1月29日公告，预计2025年归母净利润亏损2.13亿元到3.19亿元，上年同期亏损1.23亿元。受外 部宏观经济、行业竞争格局加剧等影响下，公司结合内外部环境与下属两家医院实际及预期经营情况、 医疗行业政策变化等综合因素考虑，基于谨慎性原则，对两家医院形成的商誉计提了商誉减值准备，对 本报告期业绩造成较大影响，是导致本期业绩预亏的主要原因。 ...

Market Overview - The Shanghai Composite Index closed at 4114.00 points, above the annual line, with a change of 0.29% [1] - The total trading volume of A-shares reached 27,322.16 million yuan [1] Stocks Breaking Annual Line - A total of 129 A-shares have surpassed the annual line today [1] - Notable stocks with significant deviation rates include: - Xinlicheng (8.92%) - Junzheng Group (8.59%) - Tiandi Online (7.60%) [1] Stock Performance Details - The following stocks showed notable performance: - Xinlicheng: Today's change of 9.83%, turnover rate of 9.53%, latest price at 2.57 yuan [1] - Junzheng Group: Today's change of 8.68%, turnover rate of 5.01%, latest price at 5.76 yuan [1] - Tiandi Online: Today's change of 9.99%, turnover rate of 7.71%, latest price at 20.26 yuan [1] - Other stocks with smaller deviation rates include: - Hemai Co., Ltd. - Wukuang Capital - Huadian Liaoning Energy [1]

Core Viewpoint - Zhejiang Shapuaisi Pharmaceutical Co., Ltd. has received approval for the supplementary application of Diflunisal tablets, which enhances the company's product line and market competitiveness [1][5]. Group 1: Drug Approval Details - Drug Name: Diflunisal Tablets [2][3] - Dosage Form: Tablet [2][3] - Specifications: 0.25g and 0.5g [2][3] - Registration Category: Chemical Drug [2][3] - License Holder and Manufacturer: Zhejiang Shapuaisi Pharmaceutical Co., Ltd. [2][3] - Approval Conclusion: The drug has passed the consistency evaluation of generic drug quality and efficacy [1][2]. Group 2: R&D Investment - The cumulative R&D investment for the Diflunisal tablet project is approximately 7.1492 million RMB [4]. Group 3: Market Impact - The approval of Diflunisal tablets is expected to enrich the company's product line and enhance the market competitiveness of this product [5].

（文章来源：证券日报） 证券日报网讯 1月15日，莎普爱思发布公告称，近日，公司收到国家药品监督管理局核发的二氟尼柳片 的《药品补充申请批准通知书》（通知书编号：2026B00097、2026B00098）。 ...

Group 1 - Siyuan Electric reported a total operating revenue of 21.205 billion yuan for 2025, a year-on-year increase of 37.18%, with a net profit attributable to shareholders of 3.163 billion yuan, up 54.35% year-on-year [1] - VisiOn expects a negative net profit for 2025, indicating a loss in operating performance [2] - Chongqing Steel anticipates a net loss of 2.5 billion to 2.8 billion yuan for 2025, which is an improvement from a net loss of 3.196 billion yuan in the previous year [3] - Lianfa Co. forecasts a net profit of 280 million to 320 million yuan for 2025, representing a year-on-year growth of 38.92% to 58.77% [4] Group 2 - CICC announced that the audit work related to the absorption merger with Dongxing Securities and Xinda Securities has not yet been completed [5] - Dalong Real Estate's subsidiary won a project bid worth 763 million yuan [6] - Zhongchuang Zhiling plans to issue convertible bonds to raise no more than 4.35 billion yuan for various projects [7] - Jintong Co. intends to acquire a 24% stake in Jinsha Molybdenum for 1.731 billion yuan [8] Group 3 - Nami Technology expects a net profit of 128 million to 145 million yuan for 2025, an increase of 54.51% to 75.03% year-on-year [9] - China State Construction reported a new contract total of 4.5458 trillion yuan for 2025, a 1% increase year-on-year [12] - China Metallurgical Group's new contract amount for 2025 is expected to decrease by 10.8% to 1.1136 trillion yuan [13] Group 4 - Beiding Co. reported a net profit of 111 million yuan for 2025, a year-on-year increase of 59.05% [14] - Southwest Securities expects a net profit of 1.028 billion to 1.098 billion yuan for 2025, an increase of 47% to 57% [15] - China Eastern Airlines reported a 4.93% year-on-year increase in passenger capacity for December 2025 [20] Group 5 - *ST Aowei's stock may be delisted due to a closing price below par value [21] - Yilian Network expects a net profit of 2.542 billion to 2.648 billion yuan for 2025, a decrease of 0% to 4% year-on-year [22] - Huochen Co. anticipates a net profit of 420 million to 540 million yuan for 2025, recovering from a loss of 2 million yuan in the previous year [17] Group 6 - Guoli Electronics expects a net profit of 68 million to 80 million yuan for 2025, an increase of 124.89% to 164.57% [28] - Jinchuan Group forecasts a net profit of 11 billion to 12 billion yuan for 2025, a year-on-year increase of 73.57% to 89.34% [41] - Triangle Tire plans to invest 3.219 billion yuan in a new tire project in Cambodia [42]